Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System | Zendy

Marika Plöthner | Zendy; Mike Klora | Zendy; Daniel Rudolph | Zendy; Johann-Matthias Graf von der Schulenburg | Zendy

Open Access

Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System

Author(s) -

Marika Plöthner,

Mike Klora,

Daniel Rudolph,

Johann-Matthias Graf von der Schulenburg

Publication year - 2017

Publication title -

public health genomics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.701

H-Index - 51

eISSN - 1662-8063

pISSN - 1662-4246

DOI - 10.1159/000477559

Subject(s) - german , genetic testing , health care , business , medicine , public economics , environmental health , economics , economic growth , archaeology , history

The global genetic direct-to-consumer (DTC) market will reach a volume of USD 230 billion in 2018. The expenditures for this genetic analysis are borne by the customer, whereas consequential costs may arise for a solidarily financed system. In a first step, it is essential to gain an overview of the currently available offer in the German setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research